CD274 and neoplasm: At the tumor microenvironment’s temperature, the hydrogel undergoes a phase transition, releasing the anti-PD-L1 blocks the PD-1/PD-L1 interaction between tumor cells and T lymphocytes, thereby reactivating T lymphocyte-mediated anti-tumor activity.